Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B LIVINGSTON

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group StudyG E Goodman, J J Crowley, J C Blasko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group StudyR B Livingston, B R Griffin, C S Higano, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group studyS M Grunberg, J J Crowley, R B Livingston, et al.
The Annals of Thoracic Surgery|August 1, 1994
Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology GroupV W Rusch, K S Albain, J J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1991
A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group studyJ K Weick, J Crowley, R B Natale, et al.
American Journal of Clinical Oncology|October 16, 1999
'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II StudyG K Ellis, S Green, R B Livingston, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1993
Effect of delay in radiation in the combined modality treatment of breast cancerT A Buchholz, M M Austin-Seymour, R E Moe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposideM S Tallman, F R Appelbaum, D Amos, et al.
Cancer|August 15, 1993
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data baseK S Albain, J J Crowley, L Hutchins, et al.
The New England Journal of Medicine|January 28, 1999
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposideA T Turrisi, K Kim, R Blum, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group StudyG E Goodman, J J Crowley, J C Blasko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group StudyR B Livingston, B R Griffin, C S Higano, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group studyS M Grunberg, J J Crowley, R B Livingston, et al.
The Annals of Thoracic Surgery|August 1, 1994
Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology GroupV W Rusch, K S Albain, J J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1991
A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group studyJ K Weick, J Crowley, R B Natale, et al.
American Journal of Clinical Oncology|October 16, 1999
'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II StudyG K Ellis, S Green, R B Livingston, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1993
Effect of delay in radiation in the combined modality treatment of breast cancerT A Buchholz, M M Austin-Seymour, R E Moe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposideM S Tallman, F R Appelbaum, D Amos, et al.
Cancer|August 15, 1993
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data baseK S Albain, J J Crowley, L Hutchins, et al.
The New England Journal of Medicine|January 28, 1999
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposideA T Turrisi, K Kim, R Blum, et al.
Pageof 20